The number of individuals filling prescriptions for all medications decreased “considerably” in the early days of the COVID-19 pandemic, researchers wrote in JAMA Internal Medicine.However, the number of individuals who filled prescriptions for bupreno…
Author: Healio ophthalmology
COVID-19 lockdowns may negatively affect myopia progression in young children
There may be an association between home confinement due to the COVID-19 pandemic and a myopic shift in children aged 6 to 8 years in China, according to a study.“The prevalence of myopia increased 1.4 to 3 times in 2020 compared with the previous 5 ye…
Q&A: Physicians often attacked on social media for public health messaging
A survey conducted before the COVID-19 pandemic showed that almost one in four physicians were attacked on social media. This number is expected to be even higher now, according to one of the study authors.“If we were to do this study again now, I can …
Perspective: Carlos Buznego, MD, on recent Glaukos data
The iStent infinite is under evaluation in an investigational device exemption FDA trial as a MIGS device that is performed independent of cataract surgery.As we know, the original iStent, the iStent inject (both Glaukos) and the Hydrus (Ivantis) were …
Biden reverses ban on transgender troops
President Joseph R. Biden Jr. on Jan. 25 issued an executive order that allows transgender men and women to serve in the military again.The executive order reverses an order from President Donald J. Trump, who in 2017 announced that transgender troops …
Q&A: New studies with DARC technology show potential for early detection of wet AMD
In a paper in Expert Review of Molecular Diagnostics, Maria Francesca Cordeiro, MD, and colleagues demonstrated that algorithm-aided detection of apoptosing retinal cells can identify early endothelial neovascular activity.This method predicted onset o…
Phentolamine mesylate ophthalmic solution may have utility in presbyopia
Phentolamine mesylate ophthalmic solution improved distance corrected near visual acuity and reduced pupil diameter in patients with glaucoma and presbyopia, according to a study.“Presbyopia has a significantly negative impact on quality of life. … C…
Faricimab meets primary endpoints in phase 3 wet AMD studies
Faricimab met its primary endpoint in two phase 3 studies, with injections every 16 weeks achieving noninferior visual acuity outcomes compared aflibercept every 8 weeks in wet age-related macular degeneration, according to a press release.In the TENAY…
Study updates top January retina coverage
News detailing the first patient dosed in a clinical trial for AXT107 led retina coverage in the beginning of January.Read the rest of the top-performing retina articles below.First patient dosed in AXT107 clinical trial for DMEThe first patient has be…
Ocuphire news leads January refractive surgery coverage
The leading refractive surgery stories on Healio/OSN so far this year include a guest blogger examining the benefits of in-office premium procedures.Read the best-performing articles from the first weeks of 2021 below.Ocuphire initiates phase 3 study o…
Untethered portability of retina laser system allows for expanded treatment
The portability of retina diagnostic and treatment tools, such as the recently approved Lion green laser system, allows surgeons to provide care for patients in nontraditional settings.The Lion (Norlase), which combines the Keeler Vantage Plus diagnost…
Chemotherapy may offer alternative to enucleation in certain retinoblastoma cases
A conservative approach can be considered as a safe alternative to primary enucleation in children with advanced retinoblastoma in some cases, according to a presenter.“Chemotherapy with appropriate focal consolidation can help provide eye salvage in a…
Woman presents with gradually worsening vision
A 45-year-old woman presented to the New England Eye Center comprehensive ophthalmology clinic for evaluation of gradually worsening blurry vision in both eyes over the past 1 to 2 years.The blurry vision was associated with worsening glare under brigh…
Underrepresentation issues persist in ophthalmology
Diversity and inclusion in the workplace, in a profession or in any setting for that matter are complex and challenging subjects to discuss. With some hesitation, I will share a few personal thoughts.First, I have traveled globally for 40 years, and to…
Real-world study highlights need to improve early wet AMD diagnosis
A real-world analysis conducted on a large ophthalmology registry confirmed that best results with anti-VEGF injections in age-related macular degeneration are obtained in patients who initiate treatment when visual acuity is still good.Unfortunately, …
Patient history key for treating corneal infiltrates
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.Infectious keratitis is one of the most commonl…
New Year’s resolutions: A reset for 2021
Wow! 2020 sure did not turn out quite the way we expected, did it? 2020, the year of the eye doctor. So not.A year that started out with a rush got clobbered with the lockdowns of March. Our communal financial carnage was amplified by a blanket “stand …
Associations provide pathways for underrepresented minorities to succeed
The influence of race and racism in ophthalmology is evident in the numbers.Of 94,243 students enrolled in U.S. medical schools in 2020-2021, 48.5% are identified as white while 7.6% are identified as Black or African American, according to Association…
Angle alpha, angle kappa play role in good IOL centration
For cataract surgery, when we implant the IOL, the closer the optic is to the center of vision, the better it is for visual outcomes.This is particularly true for IOLs that have diffractive rings such as in trifocal and bifocal IOLs, but also for newer…
Positive results reported for SURF-201 in treatment of postop pain, inflammation
SURF-201 met its primary endpoints in a phase 2 trial investigating the therapy in the treatment of post-cataract surgery pain and inflammation, according to a press release from Surface Ophthalmics.In a trial of 91 patients, SURF-201 (betamethasone 0….